Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Bo Wang (NPI 1619357365)

Field	Value
Entity Type	Individual
Organization	Bo Wang
Address	444 Nw Elks Dr
City	Corvallis
State	OR
ZIP	97330
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	June 8, 2015

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider's Medicare billing is concentrated and Medicare is the sole public payer on file: lifetime Medicare revenue is $1.1M and there is no Medicaid billing on file, so the practice is effectively single‑payer at the public-program level. The precomputed metric shows the top 3 Medicare codes account for 91.0% of total Medicare revenue, signaling a high dependence on a very small set of services for revenue generation.

Revenue is dominated by high-cost immunotherapy agents: J9271 (pembrolizumab) accounts for $714K or 64.3% of the provider's Medicare revenue and J9299 (nivolumab) accounts for $268.8K or 24.2%. Together these two drug codes drive nearly all reimbursement, while the highest-volume chemotherapy administration code in the top three, 96413, contributes only $26.9K (2.4%).

Business and service-line signals are consistent with an oncology infusion practice: the mix is centered on infusion drugs (J9271, J9299) plus chemotherapy administration codes such as 96413 and add-on infusion codes (96417, 96411, 96401), and support services like lab testing (80053, 85025) and E/M visits (99215, 99214). This profile indicates onsite infusion and ongoing outpatient management rather than a revenue mix driven by procedural oncology or surgery.

Competitive standing versus national Medicare peers is modest and broadly ‘typical’: J9271 ranks #577 of 1841 providers nationally (69th percentile; "typical, unremarkable volume for this code"), J9299 ranks #319 of 505 (37th percentile; "typical, unremarkable volume for this code"), and 96413 ranks #2058 of 7514 (73th percentile; "typical, unremarkable volume for this code"). These percentiles indicate the provider is not a dominant national center for these therapies but has a solid, expected presence for J9271.

Several supporting codes and volumes reinforce routine outpatient oncology operations: E/M codes 99215 ($19.7K) and 99214 ($18.6K) show ongoing clinical management revenue, while point-of-care labs (80053: 603 claims, $6K; 85025: 638 claims, $5.1K) and venipuncture (36415: 612 claims, $4.9K) reflect standard monitoring and infusion workflows. Most of these entries are characterized in the source as "typical, unremarkable volume for this code," indicating no extreme utilization anomalies among ancillary services.

There is measurable concentration risk tied to drug reimbursement and utilization: because J9271 alone represents $714K (64.3%) and the top three codes together represent 91.0% of Medicare revenue, changes in pricing, coverage, or utilization patterns for these immunotherapy agents would likely have an outsized impact on the provider's public-payer revenue. The absence of Medicaid billing on file limits diversification across public payers.

Tenure in Medicare is established but not long-standing by some benchmarks: the NPI was enumerated 2015-06-08 (~11 years ago), indicating the provider has been active in Medicare for about a decade, which supports interpretation of the observed volume as a more mature billing pattern rather than an initial startup phase.

Statistical notes from code-level metadata show no flagged extreme outliers: many top codes are explicitly labeled in the source as "typical, unremarkable volume for this code," though a few codes appear toward lower national percentiles (for example 96415 at the 9th percentile and 96401 at the 14th percentile) and are still described as typical in the reference data. Overall, the portfolio reads as a concentrated but typical oncology infusion practice rather than one with highly unusual billing behavior.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

37 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	16,600	$40	$714K
J9299	Injection, nivolumab, 1 mg	11,200	$20	$268.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	280	$100	$26.9K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	150	$130	$19.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	200	$90	$18.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	120	$60	$7.3K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	50	$160	$7K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	600	$10	$6K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	640	$10	$5.1K
J0185	Injection, aprepitant, 1 mg	5,070	$1	$5.1K

Showing 1–10 of 37

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 37 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Bo Wang — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

37 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	4	30	8,700	$40	$430.9K
J9299	1	10	10,720	$20	$215.6K
J3490	41	50	40	$640	$42.9K
96413	14	90	150	$100	$18.2K
99214	1,266	6,070	80	$70	$10.3K
99233	1,007	1,310	70	$90	$9.1K
J0185	10	20	5,140	$1	$7.2K
99215	203	2,170	40	$100	$6.7K
99232	996	1,730	60	$60	$5.9K
96365	80	110	70	$50	$5.8K

Showing 1–10 of 37

Related Providers

Other providers that share a Tax Identification Number (TIN) with Bo Wang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oncology Associates Of Oregon P C	OR	Hematology & Oncology Physician	$0	$2M
Michael Monticelli	CO	Hematology & Oncology Physician	$1.3M	$0
Marc Uemura	OR	Internal Medicine Physician	$1M	$0
Keith Goldstein	OR	Medical Oncology Physician	$1M	$0
Jeff Sharman	OR	Medical Oncology Physician	$878.7K	$0
Benjamin Cho	OR	Medical Oncology Physician	$816K	$0
John Fitzharris	OR	Medical Oncology Physician	$672.6K	$0
Miho Dougherty	OR	Hematology & Oncology Physician	$633.2K	$0
Christopher Yasenchak	OR	Hematology & Oncology Physician	$604.5K	$0
Jonathan Gross	OR	Medical Oncology Physician	$533.5K	$0

Nearby Providers

Other providers in the same ZIP code as Bo Wang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Good Samaritan Hospital Corvallis	OR	General Acute Care Hospital	$0	$14.6M
The Corvallis Clinic P C	OR	Multi-Specialty Clinic/Center	$0	$8.1M
Samaritan Pacific Health Services, Inc.	OR	Oxygen Equipment & Supplies (DME)	$0	$7.2M
Mary's Peak Emergency Physicians	OR	Emergency Medicine Physician	$0	$4.7M
Samaritan Endoscopy LLC	OR	Ambulatory Surgical Clinic/Center	$474.4K	$3.8M
Corvallis Radiology PC	OR	Diagnostic Radiology Physician	$0	$4M
City Of Corvallis	OR	Ambulance	$458K	$2.6M
The Corvallis Clinic PC	OR	Clinical Medical Laboratory	$406K	$2.1M
Good Samaritan Hospital Corvallis	OR	Family Medicine Physician	$0	$2.5M
Benton County	OR	Federally Qualified Health Center (FQHC)	$0	$2.4M

Bo Wang — Billing Profile & Reimbursement Data

Sign up for Bo Wang — Billing Profile & Reimbursement Data policy alerts

Bo Wang — Billing Profile & Reimbursement Data

Sign up for Bo Wang — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References